We are Sorry, This Page doesn't Exist
Cramer Weighs In On GrowGeneration, Qualcomm And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Mitek Systems, Inc. (NASDAQ: MITK) is a good company. read more.....»»
Cramer Weighs In On Palantir, Workhorse And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Palantir Technologies Inc (NYSE: PLTR) is a long-term play. He thinks the cybersecurity is good and Palantir is right. read more.....»»
Cramer"s lightning round: "General Dynamics is a very good long-term hold"
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed......»»
Cramer Shares His Thoughts On Nokia, Intel And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said some industries just went away. He is not a buyer of Meredith Corporation (NYSE: MDP). read more.....»»
Cramer Comments On IHS Markit Ltd, Pinterest And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that IHS Markit Ltd (NYSE: INFO) is a really good fintech company and it should be bought. read more.....»»
Cramer Weighs In On Roku, United Airlines And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that Roku Inc (NASDAQ: ROKU) is good. It has that cord-cutting feel that he likes, so he is willing to recommend the stock. read more.....»»
Cramer"s lightning round: I think Roku is good
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed......»»
Cramer Gives His Opinion On Chipotle, Clorox And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Chipotle Mexican Grill, Inc. (NYSE: CMG) is good if you can get it under $800. He likes it because it has a great balance sheet. read more.....»»
Cramer"s lightning round: Calithera is a "very good spec"
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed......»»
Cramer"s lightning round: Nokia is a "decent spec" at $4
"Mad Money" host Jim Cramer gave his answers to callers' stock questions at rapid speed......»»
Cramer Shares His Thoughts On Twitter, Ventas And More
Jim Cramer said on CNBC's "Mad Money Lightning Round," he wouldn't sell KLA Corp (NASDAQ: KLAC). He thinks the company is in a very good situation. 0 read more.....»»
Cramer"s lightning round: I do believe that AT&T is a good stock
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed......»»
Cramer"s lightning round: Delta is good, but United Airlines is better
"Mad Money" host Jim Cramer takes calls from viewers on their favorite stocks, such as Constellation Brands, and offers his advice......»»
Cramer"s lightning round: Wendy"s is in "good shape," shares are oversold
Jim Cramer opines to the stocks of Albemarle, Iron Mountain, Realogy Holdings, Wendy's, CME Group, Annaly Capital and Hershey......»»
Cramer Gives His Opinion On Verizon, Anthem And More
Jim Cramer said on CNBC's "Mad Money Lightning Round" that Verizon Communications Inc. (NYSE: VZ) is a buy. It has a 4% yield and a good balance sheet. read more.....»»
Jim Cramer Gives His Opinion On NeoGenomics, Yeti And More
On CNBC's "Mad Money Lightning Round,"Â Jim Cramer said that NeoGenomics, Inc. (NASDAQ: NEO) is a good spec, because early diagnostic of cancer is a holy grail. read more.....»»
Cramer"s lightning round: Buy Aqua America — "Very steady, very good"
Jim Cramer takes calls about viewers' stock picks of the day and delivers answers in rapid speed......»»
Cramer"s lightning round: This CEO tells a good story, but sell the stock
Jim Cramer fields calls and deliver answers to viewers' stock picks......»»
Cramer"s lightning round: Autos are tough, but Honda has a good story
Jim Cramer takes calls and delivers answers on viewers' stock picks of the day......»»
Jim Cramer Weighs In On Nektar, L Brands And More
On CNBC's "Mad Money Lightning Round,"Â Jim Cramer said Nektar Therapeutics (NASDAQ: NKTR) is pretty good, but it's a total spec on oncology and pain. read more.....»»